NLRP3 and atherosclerosis: Another study have shown that when the function of CMA is damaged during the progression of atherosclerosis, it can increase the activation of inflammatory body NLRP3 and the secretion of IL-1β, so as to promote the progress of vascular inflammation and atherosclerosis (47).